June 20, 2025
CHICAGO — Patients treated for cervical cancer need dedicated survivorship care to address long-term symptoms and sexual health concerns. That was the conclusion of a review […]
June 20, 2025
The server at a local sushi bar — a divorced mom in her early 30s — had been feeling some discomfort in her breast. One day […]
June 19, 2025
MILAN — Is chronic lymphocytic leukemia (CLL) progression primarily driven by genetic mutations or by external cues from the tumor microenvironment? Despite major strides in targeted […]
June 19, 2025
Immune checkpoint inhibitors (ICI) are a cornerstone of non-small cell lung cancer (NSCLC) treatment, but it’s not clear whether adding chemotherapy to ICI — a common […]
June 18, 2025
CHICAGO — Two early-phase clinical trials released data at the American Society of Clinical Oncology (ASCO) 2025 annual meeting that suggest their premise — an elranatamab-based […]
June 17, 2025
MILAN — The treatment landscape for relapsed and refractory multiple myeloma (RRMM) has shifted dramatically with the emergence of immunotherapies such as chimeric antigen receptor (CAR) […]
June 17, 2025
Naval Daver, MD, who leads a number of acute myeloid leukemia (AML) research trials at MD Anderson Cancer Center in Houston, looks forward to a future […]
June 17, 2025
TOPLINE: A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free […]
June 17, 2025
TOPLINE: Analysis reveals initiating anal cancer screening at age 35 years or older among men who have sex with men (MSM) with HIV is cost-effective. A […]